Article info

Download PDFPDF

Original article
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung

Authors

  1. Correspondence to Dr Leopoldo N Segal, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Bellevue Hospital Center/New York University School of Medicine, 462 First Ave 7W54, New York, NY 10016, USA; Leopoldo.Segal{at}nyumc.org; Dr Michael D Weiden, Michael.Weiden{at}nyumc.org
View Full Text

Citation

Segal LN, Clemente JC, Wu BG, et al
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung

Publication history

  • Received March 7, 2016
  • Revised June 22, 2016
  • Accepted July 6, 2016
  • First published August 2, 2016.
Online issue publication 
December 14, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.